Health Sciences and Wellness Strategy Consulting

EY-Parthenon Health and Wellness Strategy Consulting teams help develop and deliver growth, transaction, digital and value creation strategies. We help health and life sciences organizations build greater financial and operational resilience and technical agility, supporting their future growth within an ever-changing landscape.

What the EY-Parthenon Health Sciences and Wellness Strategy Consulting teams can do for you

As the Health Sciences and Wellness industry is transforming, EY-Parthenon Health Strategy Consulting teams can help you answer some of your most critical questions:

  • How should I refine my business strategy to meet evolving customer needs and the ever-changing health and wellness landscape?
  • How can I reinvent my operating model and go-to-market strategy?
  • How can I hone my organization’s strategy to strengthen its operational resilience?
  • How can I grow market share through investment in digital innovation? How can I leverage the ecosystem to scale my products and services?
  • What type of transaction or partnership will propel our organization’s growth and pair with consumer needs?
  • What is the right strategy, to buy, build or partner, and to solve the innovation deficit?

EY-Parthenon Health and Wellness strategy professionals can advise clients on developing growth strategies by providing broad market, competitor and customer insights. But a strategy alone is not enough: we also help organizations execute strategy through real operational change. We help them transform the vision into reality by leveraging strategic, financial and operational perspectives, based on deep sector experience and firmwide knowledge to help enable end-to-end execution.

EY-Parthenon Transaction Strategy teams help clients realize their full potential through fast-tracked, better-informed decisions across the entire deal lifecycle. We guide clients from M&A or divestment strategy, planning, transaction diligence and specialized health due diligence processes, through the integration or separation phases of a transaction — to build long-term value.

EY-Parthenon Turnaround Strategy teams can work with stakeholders to rapidly provide broad strategic, financial, operational, tax, turnaround and restructuring advice to help address business issues in critical and complex situations. From value creation to restructuring, we can help when health and life sciences organizations face financial or operational challenges.

Through Health and Wellness Strategy Consulting, EY-Parthenon teams help leaders design and deliver transformative strategies to build long-term value.

The future of commercial health benefits

Learn about the future of commercial benefits from the 2024 EY-Parthenon Employee Health Benefits Survey.

Chess pieces

Our latest thinking

How to define and execute on a successful retail health business model

The health care industry has seen tremendous investment in retail health but has had mixed results. Read more

How health care payers are focusing IT spending as costs rise

Download The 2023 EY-Parthenon and KLAS Research Payer Tech Study to discover where payers are making strategic health care IT investments to improve operations.

How a major health provider is putting care into patients’ hands

Learn how a leading health care system used digital transformation to enhance its telehealth application and better serve both patients and providers.

How life sciences can make the right deals in a time of change

Life sciences companies are returning to dealmaking amid cost and revenue pressures – how will they find the right deals to secure value? Learn more.

How to give health consumers the access and experience they value most

The EY Global Consumer Health Survey 2023 findings suggest health executives should focus on access to care, cost and experience factors. Learn more.

Virtual and in-person care merge for a healthier future

Health systems should seize on recent progress to push toward new models that seamlessly integrate virtual, home-based and in-person care. Learn more.

How value-based care can help boost health system revenue

Risk contracting for value-based care can provide long-term growth for some health care systems. Read the EY-Parthenon analysis.

Key steps for improving biopharma expansion into new markets

As biopharma companies look to new markets for needed growth, leaders need to tailor the expansion approach to the nuances of each market. Learn more.


    Access immediate support for your growth strategy
    Connect with EY-Parthenon professionals today to help pursue your growth potential.